CVRx

CVRx plans to raise up to $75m in an initial public offering and plans to be listed on Nasdaq under the ticker CVRX. The Minneapolis company markets Barostim Neo, the second-generation of its implant

The US Food and Drug Administration approved an original PMA for CVRx Inc. ’s Barostim Neo baroreflex activation therapy device to treat heart failure based on results from the BeAT HF trial. Bar

Just months after ending his tenure as chair of the medical device lobby group AdvaMed, Nadim Yared is the new chair of the Medical Device Innovation Consortium, a highly influential public-private pa

While repealing the medical device excise tax is still the No. 1 issue for AdvaMed, Stryker Corp. CEO Kevin Lobo, who has been named the new AdvaMed board chair, has outlined four top priorities as